Log In
Print
BCIQ
Print
Print this Print this
 

Arcapta Neohaler, Onbrez Breezhaler, Onbrez Inhalation Capsules, indacaterol (QAB149)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionLong-acting adrenergic receptor beta 2 agonist (LABA)
Molecular Target Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist
Therapeutic ModalityMedical Devices: Drug/device combination
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat airflow obstruction in chronic obstructive pulmonary disease (COPD) patients; Treat chronic obstructive pulmonary disease (COPD); Treat mild to moderate chronic obstructive pulmonary disease (COPD); Treat moderate to severe chronic obstructive pulmonary disease (COPD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today